Sonde wants to lis­ten for dis­ease — M Ven­tures heard the Boston biotech, and led a $16M round to su­per­charge re­search

Sight, touch and even smell are in­tu­itive and large­ly sci­en­tif­i­cal­ly-backed tools used to di­ag­nose dis­ease, and re­searchers are even eval­u­at­ing the clin­i­cal po­ten­tial of  breath analy­sis. Sound — the fi­nal fron­tier — has been gain­ing trac­tion as a health care tool, and Boston-based biotech Sonde is in the mix, work­ing on de­vel­op­ing con­sumer-friend­ly tech­nol­o­gy to dis­cern ill­ness by an­a­lyz­ing sub­tle changes in voice.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER